Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines

 

 Buy Article Permissions and Reprints

The risk of endoscopy in patients on antithrombotics depends on the risks of procedural haemorrhage vs. thrombosis due to discontinuation of therapy.

P2Y12 receptor antagonists (clopidogrel, prasugrel, ticagrelor): For low-risk endoscopic procedures we recommend continuing P2Y12 receptor antagonists as single or dual antiplatelet therapy (low quality evidence, strong recommendation);
For high-risk endoscopic procedures in patients at low thrombotic risk, we recommend discontinuing P2Y12 receptor antagonists five days before the procedure (moderate quality evidence, strong recommendation). In patients on dual antiplatelet therapy, we suggest continuing aspirin (low quality evidence, weak recommendation).

For high-risk endoscopic procedures in patients at high thrombotic risk, we recommend continuing aspirin and liaising with a cardiologist about the risk/benefit of discontinuation of P2Y12 receptor antagonists (high quality evidence, strong recommendation).

Warfarin: The advice for warfarin is fundamentally unchanged from BSG 2008 guidance.

Direct Oral Anticoagulants (DOAC): For low-risk endoscopic procedures we suggest omitting the morning dose of DOAC on the day of the procedure (very low quality evidence, weak recommendation). For high-risk endoscopic procedures, we recommend that the last dose of DOAC be taken ≥ 48 hours before the procedure (very low quality evidence, strong recommendation). For patients on dabigatran with CrCl (or estimated glomerular filtration rate, eGFR) of 30 – 50 mL/min we recommend that the last dose of DOAC be taken 72 hours before the procedure (very low quality evidence, strong recommendation). In any patient with rapidly deteriorating renal function a haematologist should be consulted (low quality evidence, strong recommendation).

• References

• 1 Gralnek IM, Dumonceau JM, Kuipers EJ et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: a1-a46
  Article in Thieme ConnectPubMedGoogle Scholar
• 2 Veitch AM, Baglin TP, Gershlick AH et al. Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. Gut 2008; 57: 1322-1329
  CrossrefPubMedGoogle Scholar
• 3 Boustiere C, Veitch A, Vanbiervliet G et al. Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2011; 43: 445-461
  Article in Thieme ConnectPubMedGoogle Scholar
• 4 Agree Next Steps Consortium. The AGREE II Instrument (Electronic version). 2009 http://www.agreetrust.org
  PubMedGoogle Scholar
• 5 Guyatt GH, Oxman AD, Vist GE et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-926
  CrossrefPubMedGoogle Scholar
• 6 Friedland S, Sedehi D, Soetikno R. Colonoscopic polypectomy in anticoagulated patients. World J Gastroenterol 2009; 15: 1973-1976
  CrossrefPubMedGoogle Scholar
• 7 Horiuchi A, Nakayama Y, Kajiyama M et al. Removal of small colorectal polyps in anticoagulated patients: a prospective randomized comparison of cold snare and conventional polypectomy. Gastrointest Endosc 2014; 79: 417-423
  CrossrefPubMedGoogle Scholar
• 8 Gavin DR, Valori RM, Anderson JT et al. The national colonoscopy audit: a nationwide assessment of the quality and safety of colonoscopy in the UK. Gut 2013; 62: 242-249
  CrossrefPubMedGoogle Scholar
• 9 Wexner SD, Garbus JE, Singh JJ et al. A prospective analysis of 13,580 colonoscopies. Reevaluation of credentialing guidelines. Surg Endosc 2001; 15: 251-261
  CrossrefPubMedGoogle Scholar
• 10 Ellul P, Fogden E, Simpson CL et al. Downstaging of colorectal cancer by the National Bowel Cancer Screening programme in England: first round data from the first centre. Colorectal Dis 2010; 12: 420-422
  CrossrefPubMedGoogle Scholar
• 11 Bowles CJ, Leicester R, Romaya C et al. A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow?. Gut 2004; 53: 277-283
  CrossrefPubMedGoogle Scholar
• 12 Gibbs DH, Opelka FG, Beck DE et al. Postpolypectomy colonic hemorrhage. Dis Colon Rectum 1996; 39: 806-810
  CrossrefPubMedGoogle Scholar
• 13 Rosen L, Bub DS, Reed 3rd JF et al. Hemorrhage following colonoscopic polypectomy. Dis Colon Rectum 1993; 36: 1126-1131
  CrossrefPubMedGoogle Scholar
• 14 Sieg A, Hachmoeller-Eisenbach U, Eisenbach T. Prospective evaluation of complications in outpatient GI endoscopy: a survey among German gastroenterologists. Gastrointest Endosc 2001; 53: 620-627
  CrossrefPubMedGoogle Scholar
• 15 Witt DM, Delate T, McCool KH et al. Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy. J Thromb Haemost 2009; 7: 1982-1989
  CrossrefPubMedGoogle Scholar
• 16 Eisen GM, Baron TH, Dominitz JA et al. Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc 2002; 55: 775-779
  CrossrefPubMedGoogle Scholar
• 17 Douketis JD, Spyropoulos AC, Kaatz S et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med 2015; 373: 823-833
  CrossrefPubMedGoogle Scholar
• 18 Gage BF, Waterman AD, Shannon W et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864-2870
  CrossrefPubMedGoogle Scholar
• 19 Nishimura RA, Otto CM, Bonow RO et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: 2438-2488
  CrossrefPubMedGoogle Scholar
• 20 Szekely P. Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease. Br Med J 1964; 1: 1209-1212
  CrossrefPubMedGoogle Scholar
• 21 Meurin P, Tabet JY, Weber H et al. Low-molecular-weight heparin as a bridging anticoagulant early after mechanical heart valve replacement. Circulation 2006; 113: 564-569
  CrossrefPubMedGoogle Scholar
• 22 Seshadri N, Goldhaber SZ, Elkayam U et al. The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: an evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients. Am Heart J 2005; 150: 27-34
  CrossrefPubMedGoogle Scholar
• 23 Shapira Y, Sagie A, Battler A. Low-molecular-weight heparin for the treatment of patients with mechanical heart valves. Clin Cardiol 2002; 25: 323-327
  CrossrefPubMedGoogle Scholar
• 24 Spyropoulos AC, Turpie AG, Dunn AS et al. Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry). Am J Cardiol 2008; 102: 883-889
  CrossrefPubMedGoogle Scholar
• 25 Hui AJ, Wong RM, Ching JY et al. Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases. Gastrointest Endosc 2004; 59: 44-48
  CrossrefPubMedGoogle Scholar
• 26 Nelson DB, Freeman ML. Major hemorrhage from endoscopic sphincterotomy: risk factor analysis. J Clin Gastroenterol 1994; 19: 283-287
  CrossrefPubMedGoogle Scholar
• 27 Shiffman ML, Farrel MT, Yee YS. Risk of bleeding after endoscopic biopsy or polypectomy in patients taking aspirin or other NSAIDS. Gastrointest Endosc 1994; 40: 458-462
  CrossrefPubMedGoogle Scholar
• 28 Yousfi M, Gostout CJ, Baron TH et al. Postpolypectomy lower gastrointestinal bleeding: potential role of aspirin. Am J Gastroenterol 2004; 99: 1785-1789
  CrossrefPubMedGoogle Scholar
• 29 Cho SJ, Choi IJ, Kim CG et al. Aspirin use and bleeding risk after endoscopic submucosal dissection in patients with gastric neoplasms. Endoscopy 2012; 44: 114-121
  Article in Thieme ConnectPubMedGoogle Scholar
• 30 Takeuchi T, Ota K, Harada S et al. The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection. BMC Gastroenterol 2013; 13: 136
  CrossrefPubMedGoogle Scholar
• 31 Bahin FF, Naidoo M, Williams SJ et al. Prophylactic endoscopic coagulation to prevent bleeding after wide-field endoscopic mucosal resection of large sessile colon polyps. Clin Gastroenterol Hepatol 2015; 13: 724-730 e1–e2
  CrossrefPubMedGoogle Scholar
• 32 Burgess NG, Metz AJ, Williams SJ et al. Risk factors for intraprocedural and clinically significant delayed bleeding after wide-field endoscopic mucosal resection of large colonic lesions. Clin Gastroenterol Hepatol 2014; 12: 651-661 e1–e3
  CrossrefPubMedGoogle Scholar
• 33 Metz AJ, Bourke MJ, Moss A et al. Factors that predict bleeding following endoscopic mucosal resection of large colonic lesions. Endoscopy 2011; 43: 506-511
  Article in Thieme ConnectPubMedGoogle Scholar
• 34 Biondi-Zoccai GG, Lotrionte M, Agostoni P et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 2006; 27: 2667-2674
  CrossrefPubMedGoogle Scholar
• 35 Maulaz AB, Bezerra DC, Michel P et al. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol 2005; 62: 1217-1220
  CrossrefPubMedGoogle Scholar
• 36 Oscarsson A, Gupta A, Fredrikson M et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth 2010; 104: 305-312
  CrossrefPubMedGoogle Scholar
• 37 Geiger J, Brich J, Honig-Liedl P et al. Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel. Arterioscler Thromb Vasc Biol 1999; 19: 2007-2011
  CrossrefPubMedGoogle Scholar
• 38 Budaj A, Yusuf S, Mehta SR et al. Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups. Circulation 2002; 106: 1622-1626
  CrossrefPubMedGoogle Scholar
• 39 Korte W, Cattaneo M, Chassot PG et al. Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (OGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC). Thromb Haemost 2011; 105: 743-749
  Article in Thieme ConnectPubMedGoogle Scholar
• 40 NICE. Myocardial infarction with ST-segment elevation: acute management. Available at: https://www.nice.org.uk/guidance/cg167
  PubMedGoogle Scholar
• 41 Bonaca MP, Scirica BM, Braunwald E et al. Coronary stent thrombosis with vorapaxar versus placebo: results from the TRA 2 degrees P-TIMI 50 trial. J Am Coll Cardiol 2014; 64: 2309-2317
  CrossrefPubMedGoogle Scholar
• 42 Magnani G, Bonaca MP, Braunwald E et al. Efficacy and safety of vorapaxar as approved for clinical use in the United States. J Am Heart Assoc 2015; 4: e001505
  CrossrefPubMedGoogle Scholar
• 43 Morrow DA, Braunwald E, Bonaca MP et al. Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med 2012; 366: 1404-1413
  CrossrefPubMedGoogle Scholar
• 44 Wallentin L, Becker RC, Budaj A et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009; 361: 1045-1057
  CrossrefPubMedGoogle Scholar
• 45 Wiviott SD, Braunwald E, McCabe CH et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007; 357: 2001-2015
  CrossrefPubMedGoogle Scholar
• 46 Zeymer U, Hochadel M, Lauer B et al. Use, efficacy and safety of prasugrel in patients with ST segment elevation myocardial infarction scheduled for primary percutaneous coronary intervention in clinical practice. Results of the prospective ATACS-registry. Int J Cardiol 2015; 184C: 122-127
  PubMedGoogle Scholar
• 47 Iakovou I, Schmidt T, Bonizzoni E et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130
  CrossrefPubMedGoogle Scholar
• 48 Gershlick AH, Richardson G. Drug eluting stents. BMJ 2006; 333: 1233-1234
  CrossrefPubMedGoogle Scholar
• 49 Stone GW, Midei M, Newman W et al. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial. Circulation 2009; 119: 680-686
  CrossrefPubMedGoogle Scholar
• 50 Feres F, Costa RA, Abizaid A et al. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. JAMA 2013; 310: 2510-2522
  PubMedGoogle Scholar
• 51 Kereiakes DJ, Yeh RW, Massaro JM et al. Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial. JAMA 2015; 313: 1113-1121
  CrossrefPubMedGoogle Scholar
• 52 Mehran R, Baber U, Steg PG et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet 2013; 382: 1714-1722
  CrossrefPubMedGoogle Scholar
• 53 Connolly SJ, Ezekowitz MD, Yusuf S et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151
  CrossrefPubMedGoogle Scholar
• 54 Schulman S, Kearon C, Kakkar AK et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 2009; 361: 2342-2352
  CrossrefPubMedGoogle Scholar
• 55 Bauersachs R, Berkowitz SD, Brenner B et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010; 363: 2499-2510
  CrossrefPubMedGoogle Scholar
• 56 Patel MR, Mahaffey KW, Garg J et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883-891
  CrossrefPubMedGoogle Scholar
• 57 Agnelli G, Buller HR, Cohen A et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 2013; 369: 799-808
  CrossrefPubMedGoogle Scholar
• 58 Granger CB, Alexander JH, McMurray JJ et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981-992
  CrossrefPubMedGoogle Scholar
• 59 Giugliano RP, Ruff CT, Braunwald E et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013; 369: 2093-2104
  CrossrefPubMedGoogle Scholar
• 60 Ansell JE, Bakhru SH, Laulicht BE et al. Use of PER977 to reverse the anticoagulant effect of edoxaban. N Engl J Med 2014; 371: 2141-2142
  CrossrefPubMedGoogle Scholar
• 61 Lu G, DeGuzman FR, Hollenbach SJ et al. A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa. Nat Med 2013; 19: 446-451
  CrossrefPubMedGoogle Scholar
• 62 Pollack Jr CV, Reilly PA, Eikelboom J et al. Idarucizumab for dabigatran reversal. N Engl J Med 2015; 373: 511-520
  CrossrefPubMedGoogle Scholar
• 63 Baglin T. Clinical use of new oral anticoagulant drugs: dabigatran and rivaroxaban. Br J Haematol 2013; 163: 160-167
  PubMedGoogle Scholar
• 64 Schulman S, Carrier M, Lee AY et al. Perioperative management of dabigatran: a prospective cohort study. Circulation 2015; 132: 167-173
  CrossrefPubMedGoogle Scholar
• 65 Abraham NS, Singh S, Alexander GC et al. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study. BMJ 2015; 350: h1857
  CrossrefPubMedGoogle Scholar
• 66 Blech S, Ebner T, Ludwig-Schwellinger E et al. The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans. Drug Metabolsim and Disposition 2008; 36: 386-399
  PubMedGoogle Scholar
• 67 van Es N, Coppens M, Schulman S et al. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood 2014; 124: 1968-1975
  CrossrefPubMedGoogle Scholar
• 68 Stangier J, Feuring M. Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran. Blood Coagulation and Fibrinolysis 2012; 23: 138-143
  CrossrefPubMedGoogle Scholar
• 69 Asmis LM, Alberio L, Angelillo-Scherrer A et al. Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests A study in 9 Swiss laboratories. Thrombosis Research 2011; 129: 492-498
  PubMedGoogle Scholar
• 70 Samama MM, Contant G, Spiro TE et al. Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls. Thromb Haemost 2012; 107: 379-387
  Article in Thieme ConnectPubMedGoogle Scholar
• 71 Samama MM, Martinoli JL, Le Flem L et al. Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor. Thrombosis and Haemostasis 2010; 103: 815-825
  Article in Thieme ConnectPubMedGoogle Scholar
• 72 Beyer-Westendorf J, Gelbricht V, Forster K et al. Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry. Eur Heart J 2014; 35: 1888-1896
  CrossrefPubMedGoogle Scholar
• 73 Douketis JD, Healey JS, Brueckmann M et al. Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial. Thromb Haemost 2015; 113: 625-632
  Article in Thieme ConnectPubMedGoogle Scholar
• 74 Lip GY, Huber K, Andreotti F et al. Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2010; 31: 1311-1318
  CrossrefPubMedGoogle Scholar
• 75 Dewilde WJ, Janssen PW, Verheugt FW et al. Triple therapy for atrial fibrillation and percutaneous coronary intervention: a contemporary review. J Am Coll Cardiol 2014; 64: 1270-1280
  CrossrefPubMedGoogle Scholar
• 76 Rubboli A, Agewall S, Huber K et al. New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint. Int J Cardiol 2015; 196: 133-138
  CrossrefPubMedGoogle Scholar
• 77 Eerenberg ES, Kamphuisen PW, Sijpkens MK et al. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation 2011; 124: 1573-1579
  CrossrefPubMedGoogle Scholar
• 78 Schulman S, Crowther MA. How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch. Blood 2012; 119: 3016-3023
  CrossrefPubMedGoogle Scholar
• 79 Weitz JI, Quinlan DJ, Eikelboom JW. Periprocedural management and approach to bleeding in patients taking dabigatran. Circulation 2012; 126: 2428-2432
  CrossrefPubMedGoogle Scholar
• 80 Cappell MS, Abdullah M. Management of gastrointestinal bleeding induced by gastrointestinal endoscopy. Gastroenterol Clin North Am 2000; 29: 125-167 , vi–vii
  CrossrefPubMedGoogle Scholar
• 81 Macrae FA, Tan KG, Williams CB. Towards safer colonoscopy: a report on the complications of 5000 diagnostic or therapeutic colonoscopies. Gut 1983; 24: 376-383
  CrossrefPubMedGoogle Scholar
• 82 Rogers BH, Silvis SE, Nebel OT et al. Complications of flexible fiberoptic colonoscopy and polypectomy. Gastrointest Endosc 1975; 22: 73-77
  CrossrefPubMedGoogle Scholar
• 83 Vu CK, Korman MG, Bejer I et al. Gastrointestinal bleeding after cold biopsy. Am J Gastroenterol 1998; 93: 1141-1143
  CrossrefPubMedGoogle Scholar
• 84 Ono S, Fujishiro M, Kodashima S et al. Evaluation of safety of endoscopic biopsy without cessation of antithrombotic agents in Japan. J Gastroenterol 2012; 47: 770-774
  CrossrefPubMedGoogle Scholar
• 85 Whitson MJ, Dikman AE, von Althann C et al. Is gastroduodenal biopsy safe in patients receiving aspirin and clopidogrel? a prospective, randomized study involving 630 biopsies. J Clin Gastroenterol 2011; 45: 228-233
  CrossrefPubMedGoogle Scholar
• 86 Rutter MD, Nickerson C, Rees CJ et al. Risk factors for adverse events related to polypectomy in the English Bowel Cancer Screening Programme. Endoscopy 2014; 46: 90-97
  Article in Thieme ConnectPubMedGoogle Scholar
• 87 Choung BS, Kim SH, Ahn DS et al. Incidence and risk factors of delayed postpolypectomy bleeding: a retrospective cohort study. J Clin Gastroenterol 2014; 48: 784-789
  CrossrefPubMedGoogle Scholar
• 88 Gimeno-Garcia AZ, de Ganzo ZA, Sosa AJ et al. Incidence and predictors of postpolypectomy bleeding in colorectal polyps larger than 10 mm. Eur J Gastroenterol Hepatol 2012; 24: 520-526
  CrossrefPubMedGoogle Scholar
• 89 Kim JH, Lee HJ, Ahn JW et al. Risk factors for delayed post-polypectomy hemorrhage: a case-control study. J Gastroenterol Hepatol 2013; 28: 645-649
  CrossrefPubMedGoogle Scholar
• 90 Manocha D, Singh M, Mehta N et al. Bleeding risk after invasive procedures in aspirin/NSAID users: polypectomy study in veterans. Am J Med 2012; 125: 1222-1227
  CrossrefPubMedGoogle Scholar
• 91 Repici A, Hassan C, Vitetta E et al. Safety of cold polypectomy for <10mm polyps at colonoscopy: a prospective multicenter study. Endoscopy 2012; 44: 27-31
  Article in Thieme ConnectPubMedGoogle Scholar
• 92 Zhang Q, An S, Chen Z et al. Assessment of risk factors for delayed colonic post-polypectomy hemorrhage: a study of 15553 polypectomies from 2005 to 2013. PLoS One 2014; 9: e108290
  CrossrefPubMedGoogle Scholar
• 93 Sawhney MS, Salfiti N, Nelson DB et al. Risk factors for severe delayed postpolypectomy bleeding. Endoscopy 2008; 40: 115-19
  Article in Thieme ConnectPubMedGoogle Scholar
• 94 Kim HS, Kim TI, Kim WH et al. Risk factors for immediate postpolypectomy bleeding of the colon: a multicenter study. Am J Gastroenterol 2006; 101: 1333-1341
  CrossrefPubMedGoogle Scholar
• 95 Corte CJ, Burger DC, Horgan G et al. Postpolypectomy haemorrhage following removal of large polyps using mechanical haemostasis or epinephrine: a meta-analysis. United European Gastroenterol J 2014; 2: 123-130
  PubMedGoogle Scholar
• 96 Li LY, Liu QS, Li L et al. A meta-analysis and systematic review of prophylactic endoscopic treatments for postpolypectomy bleeding. Int J Colorectal Dis 2011; 26: 709-719
  CrossrefPubMedGoogle Scholar
• 97 Ji JS, Lee SW, Kim TH et al. Comparison of prophylactic clip and endoloop application for the prevention of postpolypectomy bleeding in pedunculated colonic polyps: a prospective, randomized, multicenter study. Endoscopy 2014; 46: 598-604
  Article in Thieme ConnectPubMedGoogle Scholar
• 98 Quintanilla E, Castro JL, Rabago LR et al. Is the use of prophylactic hemoclips in the endoscopic resection of large pedunculated polyps useful? A prospective and randomized study. J Interv Gastroenterol 2012; 2: 183-188
  CrossrefPubMedGoogle Scholar
• 99 Liaquat H, Rohn E, Rex DK. Prophylactic clip closure reduced the risk of delayed postpolypectomy hemorrhage: experience in 277 clipped large sessile or flat colorectal lesions and 247 control lesions. Gastrointest Endosc 2013; 77: 401-407
  CrossrefPubMedGoogle Scholar
• 100 Feagins LA, Nguyen AD, Iqbal R et al. The prophylactic placement of hemoclips to prevent delayed post-polypectomy bleeding: an unnecessary practice?. A case control study. Dig Dis Sci 2014; 59: 823-828
  PubMedGoogle Scholar
• 101 Shioji K, Suzuki Y, Kobayashi M et al. Prophylactic clip application does not decrease delayed bleeding after colonoscopic polypectomy. Gastrointest Endosc 2003; 57: 691-694
  CrossrefPubMedGoogle Scholar
• 102 Parikh ND, Zanocco K, Keswani RN et al. A cost-efficacy decision analysis of prophylactic clip placement after endoscopic removal of large polyps. Clin Gastroenterol Hepatol 2013; 11: 1319-1324
  CrossrefPubMedGoogle Scholar
• 103 Nonaka S, Oda I, Tada K et al. Clinical outcome of endoscopic resection for nonampullary duodenal tumors. Endoscopy 2015; 47: 129-135
  Google Scholar
• 104 Cipolletta L, Rotondano G, Bianco MA et al. Endoscopic resection for superficial colorectal neoplasia in Italy: a prospective multicentre study. Dig Liver Dis 2014; 46: 146-151
  CrossrefPubMedGoogle Scholar
• 105 Heresbach D, Kornhauser R, Seyrig JA et al. A national survey of endoscopic mucosal resection for superficial gastrointestinal neoplasia. Endoscopy 2010; 42: 806-813
  Article in Thieme ConnectPubMedGoogle Scholar
• 106 Qumseya BJ, Wolfsen C, Wang Y et al. Factors associated with increased bleeding post-endoscopic mucosal resection. J Dig Dis 2013; 14: 140-146
  CrossrefPubMedGoogle Scholar
• 107 Namasivayam V, Prasad GA, Lutzke LS et al. The risk of endoscopic mucosal resection in the setting of clopidogrel use. ISRN Gastroenterol 2014; 494157
  PubMedGoogle Scholar
• 108 Cao Y, Liao C, Tan A et al. Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract. Endoscopy 2009; 41: 751-757
  Article in Thieme ConnectPubMedGoogle Scholar
• 109 Koh R, Hirasawa K, Yahara S et al. Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasms. Gastrointest Endosc 2013; 78: 476-483
  CrossrefPubMedGoogle Scholar
• 110 Lim JH, Kim SG, Kim JW et al. Do antiplatelets increase the risk of bleeding after endoscopic submucosal dissection of gastric neoplasms?. Gastrointest Endosc 2012; 75: 719-727
  CrossrefPubMedGoogle Scholar
• 111 Miyahara K, Iwakiri R, Shimoda R et al. Perforation and postoperative bleeding of endoscopic submucosal dissection in gastric tumors: analysis of 1190 lesions in low- and high-volume centers in Saga, Japan. Digestion 2012; 86: 273-280
  CrossrefPubMedGoogle Scholar
• 112 Toyokawa T, Inaba T, Omote S et al. Risk factors for perforation and delayed bleeding associated with endoscopic submucosal dissection for early gastric neoplasms: analysis of 1123 lesions. J Gastroenterol Hepatol 2012; 27: 907-912
  CrossrefPubMedGoogle Scholar
• 113 Toyonaga T, Man-i M, East JE et al. 1,635 Endoscopic submucosal dissection cases in the esophagus, stomach, and colorectum: complication rates and long-term outcomes. Surg Endosc 2013; 27: 1000-1008
  CrossrefPubMedGoogle Scholar
• 114 Kim JS, Kim BW, Shin IS. Efficacy and safety of endoscopic submucosal dissection for superficial squamous esophageal neoplasia: a meta-analysis. Dig Dis Sci 2014; 59: 1862-1869
  CrossrefPubMedGoogle Scholar
• 115 Repici A, Hassan C, De Paula PessoaD et al. Efficacy and safety of endoscopic submucosal dissection for colorectal neoplasia: a systematic review. Endoscopy 2012; 44: 137-150
  Article in Thieme ConnectPubMedGoogle Scholar
• 116 Nakajima T, Saito Y, Tanaka S et al. Current status of endoscopic resection strategy for large, early colorectal neoplasia in Japan. Surg Endosc 2013; 27: 3262-3270
  CrossrefPubMedGoogle Scholar
• 117 Rahmi G, Hotayt B, Chaussade S et al. Endoscopic submucosal dissection for superficial rectal tumors: prospective evaluation in France. Endoscopy 2014; 46: 670-676
  Article in Thieme ConnectPubMedGoogle Scholar
• 118 Terasaki M, Tanaka S, Shigita K et al. Risk factors for delayed bleeding after endoscopic submucosal dissection for colorectal neoplasms. Int J Colorectal Dis 2014; 29: 877-882
  CrossrefPubMedGoogle Scholar
• 119 Suzuki S, Chino A, Kishihara T et al. Risk factors for bleeding after endoscopic submucosal dissection of colorectal neoplasms. World J Gastroenterol 2014; 20: 1839-1845
  CrossrefPubMedGoogle Scholar
• 120 Gandhi S, Narula N, Mosleh W et al. Meta-analysis: colonoscopic post-polypectomy bleeding in patients on continued clopidogrel therapy. Aliment Pharmacol Ther 2013; 37: 947-952
  CrossrefPubMedGoogle Scholar
• 121 Singh M, Mehta N, Murthy UK et al. Postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted clopidogrel therapy. Gastrointest Endosc 2010; 71: 998-1005
  CrossrefPubMedGoogle Scholar
• 122 Feagins LA, Iqbal R, Harford WV et al. Low rate of postpolypectomy bleeding among patients who continue thienopyridine therapy during colonoscopy. Clin Gastroenterol Hepatol 2013; 11: 1325-1332
  CrossrefPubMedGoogle Scholar
• 123 Feagins LA, Uddin FS, Davila RE et al. The rate of post-polypectomy bleeding for patients on uninterrupted clopidogrel therapy during elective colonoscopy is acceptably low. Dig Dis Sci 2011; 56: 2631-2638
  CrossrefPubMedGoogle Scholar
• 124 Tounou S, Morita Y, Hosono T. Continuous aspirin use does not increase post-endoscopic dissection bleeding risk for gastric neoplasms in patients on antiplatelet therapy. Endosc Int Open 2015; 3: E31-E38
  Article in Thieme ConnectPubMedGoogle Scholar
• 125 Sanomura Y, Oka S, Tanaka S et al. Continued use of low-dose aspirin does not increase the risk of bleeding during or after endoscopic submucosal dissection for early gastric cancer. Gastric Cancer 2014; 17: 489-496
  CrossrefPubMedGoogle Scholar
• 126 Matsumura T, Arai M, Maruoka D et al. Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents. BMC Gastroenterol 2014; 14: 172
  CrossrefPubMedGoogle Scholar
• 127 Nakamura M, Nishikawa J, Hamabe K et al. Risk factors for delayed bleeding from endoscopic submucosal dissection of gastric neoplasms. Scand J Gastroenterol 2012; 47: 1108-1114
  CrossrefPubMedGoogle Scholar
• 128 Cotton PB, Lehman G, Vennes J et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991; 37: 383-393
  CrossrefPubMedGoogle Scholar
• 129 Freeman ML, Nelson DB, Sherman S et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996; 335: 909-918
  CrossrefPubMedGoogle Scholar
• 130 Rey JF, Beilenhoff U, Neumann CS et al. European Society of Gastrointestinal Endoscopy (ESGE) guideline: the use of electrosurgical units. Endoscopy 2010; 42: 764-772
  Article in Thieme ConnectPubMedGoogle Scholar
• 131 Verma D, Kapadia A, Adler DG. Pure versus mixed electrosurgical current for endoscopic biliary sphincterotomy: a meta-analysis of adverse outcomes. Gastrointest Endosc 2007; 66: 283-290
  CrossrefPubMedGoogle Scholar
• 132 Zhao HC, He L, Zhou DC et al. Meta-analysis comparison of endoscopic papillary balloon dilatation and endoscopic sphincteropapillotomy. World J Gastroenterol 2013; 19: 3883-3891
  CrossrefPubMedGoogle Scholar
• 133 Liao WC, Tu YK, Wu MS et al. Balloon dilation with adequate duration is safer than sphincterotomy for extracting bile duct stones: a systematic review and meta-analyses. Clin Gastroenterol Hepatol 2012; 10: 1101-1109
  CrossrefPubMedGoogle Scholar
• 134 Cui PJ, Yao J, Zhao YJ et al. Biliary stenting with or without sphincterotomy for malignant biliary obstruction: a meta-analysis. World J Gastroenterol 2014; 20: 14033-14039
  CrossrefPubMedGoogle Scholar
• 135 Wilcox CM, Kim H, Ramesh J et al. Biliary sphincterotomy is not required for bile duct stent placement. Dig Endosc 2014; 26: 87-92
  PubMedGoogle Scholar
• 136 Hui CK, Lai KC, Yuen MF et al. Does withholding aspirin for one week reduce the risk of post-sphincterotomy bleeding?. Aliment Pharmacol Ther 2002; 16: 929-936
  CrossrefPubMedGoogle Scholar
• 137 Lee MG, Kim J, Lee SH et al. Effect of sustained use of platelet aggregation inhibitors on post-endoscopic sphincterotomy bleeding. Dig Endosc 2014; 26: 737-744
  CrossrefPubMedGoogle Scholar
• 138 Onal IK, Parlak E, Akdogan M et al. Do aspirin and non-steroidal anti-inflammatory drugs increase the risk of post-sphincterotomy hemorrhage--a case-control study. Clin Res Hepatol Gastroenterol 2013; 37: 171-176
  CrossrefPubMedGoogle Scholar
• 139 Patai A, Solymosi N, Patai AV. Does rectal indomethacin given for prevention of post-ERCP pancreatitis increase bleeding after biliary endoscopic sphincterotomy or cardiovascular mortality?. Post hoc analysis using prospective clinical trial data. Medicine (Baltimore) 2014; 93: e159
  PubMedGoogle Scholar
• 140 Hussain N, Alsulaiman R, Burtin P et al. The safety of endoscopic sphincterotomy in patients receiving antiplatelet agents: a case-control study. Aliment Pharmacol Ther 2007; 25: 579-584
  CrossrefPubMedGoogle Scholar
• 141 Rouquette O, Bommelaer G, Abergel A et al. Large balloon dilation post endoscopic sphincterotomy in removal of difficult common bile duct stones: a literature review. World J Gastroenterol 2014; 20: 7760-7766
  CrossrefPubMedGoogle Scholar
• 142 Poincloux L, Rouquette O, Privat J et al. Large-balloon dilation of the sphincter of Oddi after sphincterotomy or infundibulotomy to extract large calculi or multiple common bile duct stones without using mechanical lithotripsy. Scand J Gastroenterol 2013; 48: 246-251
  CrossrefPubMedGoogle Scholar
• 143 Harewood GC, Pochron NL, Gostout CJ. Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla. Gastrointest Endosc 2005; 62: 367-370
  CrossrefPubMedGoogle Scholar
• 144 Bohnacker S, Seitz U, Nguyen D et al. Endoscopic resection of benign tumors of the duodenal papilla without and with intraductal growth. Gastrointest Endosc 2005; 62: 551-560
  Google Scholar
• 145 Catalano MF, Linder JD, Chak A et al. Endoscopic management of adenoma of the major duodenal papilla. Gastrointest Endosc 2004; 59: 225-232
  CrossrefPubMedGoogle Scholar
• 146 Cheng CL, Sherman S, Fogel EL et al. Endoscopic snare papillectomy for tumors of the duodenal papillae. Gastrointest Endosc 2004; 60: 757-764
  CrossrefPubMedGoogle Scholar
• 147 Irani S, Arai A, Ayub K et al. Papillectomy for ampullary neoplasm: results of a single referral center over a 10-year period. Gastrointest Endosc 2009; 70: 923-932
  CrossrefPubMedGoogle Scholar
• 148 Bassan M, Bourke M. Endoscopic ampullectomy: a practical guide. J Interv Gastroenterol 2012; 2: 23-30
  CrossrefPubMedGoogle Scholar
• 149 Wang KX, Ben QW, Jin ZD et al. Assessment of morbidity and mortality associated with EUS-guided FNA: a systematic review. Gastrointest Endosc 2011; 73: 283-290
  CrossrefPubMedGoogle Scholar
• 150 Al-Haddad M, Gill KR, Raimondo M et al. Safety and efficacy of cytology brushings versus standard fine-needle aspiration in evaluating cystic pancreatic lesions: a controlled study. Endoscopy 2010; 42: 127-132
  Article in Thieme ConnectPubMedGoogle Scholar
• 151 Bruno M, Bosco M, Carucci P et al. Preliminary experience with a new cytology brush in EUS-guided FNA. Gastrointest Endosc 2009; 70: 1220-1224
  CrossrefPubMedGoogle Scholar
• 152 Lozano MD, Subtil JC, Miravalles TL et al. EchoBrush may be superior to standard EUS-guided FNA in the evaluation of cystic lesions of the pancreas: preliminary experience. Cancer Cytopathol 2011; 119: 209-214
  CrossrefPubMedGoogle Scholar
• 153 Sendino O, Fernandez-Esparrach G, Sole M et al. Endoscopic ultrasonography-guided brushing increases cellular diagnosis of pancreatic cysts: A prospective study. Dig Liver Dis 2010; 42: 877-881
  CrossrefPubMedGoogle Scholar
• 154 Thomas T, Bebb J, Mannath J et al. EUS-guided pancreatic cyst brushing: a comparative study in a tertiary referral centre. JOP 2010; 11: 163-169
  PubMedGoogle Scholar
• 155 Kien-Fong VuC, Chang F, Doig L et al. A prospective control study of the safety and cellular yield of EUS-guided FNA or Trucut biopsy in patients taking aspirin, nonsteroidal anti-inflammatory drugs, or prophylactic low molecular weight heparin. Gastrointest Endosc 2006; 63: 808-813
  CrossrefPubMedGoogle Scholar
• 156 Pereira-Lima JC, Ramires RP, Zamin Jr I et al. Endoscopic dilation of benign esophageal strictures: report on 1043 procedures. Am J Gastroenterol 1999; 94: 1497-1501
  CrossrefPubMedGoogle Scholar
• 157 Raymondi R, Pereira-Lima JC, Valves A et al. Endoscopic dilation of benign esophageal strictures without fluoroscopy: experience of 2750 procedures. Hepatogastroenterology 2008; 55: 1342-1348
  PubMedGoogle Scholar
• 158 Polese L, Angriman I, Bonello E et al. Endoscopic dilation of benign esophageal strictures in a surgical unit: a report on 95 cases. Surg Laparosc Endosc Percutan Tech 2007; 17: 477-481
  CrossrefPubMedGoogle Scholar
• 159 Williams VA, Watson TJ, Zhovtis S et al. Endoscopic and symptomatic assessment of anastomotic strictures following esophagectomy and cervical esophagogastrostomy. Surg Endosc 2008; 22: 1470-1476
  CrossrefPubMedGoogle Scholar
• 160 Metman EH, Lagasse JP, d'Alteroche L et al. Risk factors for immediate complications after progressive pneumatic dilation for achalasia. Am J Gastroenterol 1999; 94: 1179-1185
  CrossrefPubMedGoogle Scholar
• 161 Ajlouni Y, Iser JH, Gibson PR. Endoscopic balloon dilatation of intestinal strictures in Crohn's disease: safe alternative to surgery. J Gastroenterol Hepatol 2007; 22: 486-490
  CrossrefPubMedGoogle Scholar
• 162 Araujo SE, Costa AF. Efficacy and safety of endoscopic balloon dilation of benign anastomotic strictures after oncologic anterior rectal resection: report on 24 cases. Surg Laparosc Endosc Percutan Tech 2008; 18: 565-568
  CrossrefPubMedGoogle Scholar
• 163 Blomberg B, Rolny P, Jarnerot G. Endoscopic treatment of anastomotic strictures in Crohn's disease. Endoscopy 1991; 23: 195-198
  Article in Thieme ConnectPubMedGoogle Scholar
• 164 Couckuyt H, Gevers AM, Coremans G et al. Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn’s strictures: a prospective longterm analysis. Gut 1995; 36: 577-580
  CrossrefPubMedGoogle Scholar
• 165 Dear KL, Hunter JO. Colonoscopic hydrostatic balloon dilatation of Crohn's strictures. J Clin Gastroenterol 2001; 33: 315-318
  CrossrefPubMedGoogle Scholar
• 166 Thomas-Gibson S, Brooker JC, Hayward CM et al. Colonoscopic balloon dilation of Crohn's strictures: a review of long-term outcomes. Eur J Gastroenterol Hepatol 2003; 15: 485-488
  PubMedGoogle Scholar
• 167 Nomura E, Takagi S, Kikuchi T et al. Efficacy and safety of endoscopic balloon dilation for Crohn's strictures. Dis Colon Rectum 2006; 49: 59-67
  CrossrefPubMedGoogle Scholar
• 168 Sabate JM, Villarejo J, Bouhnik Y et al. Hydrostatic balloon dilatation of Crohn's strictures. Aliment Pharmacol Ther 2003; 18: 409-413
  CrossrefPubMedGoogle Scholar
• 169 Suchan KL, Muldner A, Manegold BC. Endoscopic treatment of postoperative colorectal anastomotic strictures. Surg Endosc 2003; 17: 1110-1113
  CrossrefPubMedGoogle Scholar
• 170 Boeckxstaens GE, Annese V, des Varannes SB et al. Pneumatic dilation versus laparoscopic Heller’s myotomy for idiopathic achalasia. N Engl J Med 2011; 364: 1807-1816
  Google Scholar
• 171 Ramirez FC, Dennert B, Zierer ST et al. Esophageal self-expandable metallic stents--indications, practice, techniques, and complications: results of a national survey. Gastrointest Endosc 1997; 45: 360-364
  CrossrefPubMedGoogle Scholar
• 172 Johnson E, Enden T, Noreng HJ et al. Survival and complications after insertion of self-expandable metal stents for malignant oesophageal stenosis. Scand J Gastroenterol 2006; 41: 252-256
  CrossrefPubMedGoogle Scholar
• 173 Wang MQ, Sze DY, Wang ZP et al. Delayed complications after esophageal stent placement for treatment of malignant esophageal obstructions and esophagorespiratory fistulas. J Vasc Interv Radiol 2001; 12: 465-474
  CrossrefPubMedGoogle Scholar
• 174 Neale JC, Goulden JW, Allan SG et al. Esophageal stents in malignant dysphagia: a two-edged sword?. J Palliat Care 2004; 20: 28-31
  CrossrefPubMedGoogle Scholar
• 175 Conio M, Repici A, Battaglia G et al. A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia. Am J Gastroenterol 2007; 102: 2667-2677
  CrossrefPubMedGoogle Scholar
• 176 May A, Hahn EG, Ell C. Self-expanding metal stents for palliation of malignant obstruction in the upper gastrointestinal tract. Comparative assessment of three stent types implemented in 96 implantations. J Clin Gastroenterol 1996; 22: 261-266
  CrossrefPubMedGoogle Scholar
• 177 Sabharwal T, Hamady MS, Chui S et al. A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. Gut 2003; 52: 922-926
  CrossrefPubMedGoogle Scholar
• 178 Saranovic D, Djuric-Stefanovic A, Ivanovic A et al. Fluoroscopically guided insertion of self-expandable metal esophageal stents for palliative treatment of patients with malignant stenosis of esophagus and cardia: comparison of uncovered and covered stent types. Dis Esophagus 2005; 18: 230-238
  CrossrefPubMedGoogle Scholar
• 179 Siersema PD, Hop WC, van Blankenstein M et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc 2001; 54: 145-153
  CrossrefPubMedGoogle Scholar
• 180 Vakil N, Morris AI, Marcon N et al. A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol 2001; 96: 1791-1796
  CrossrefPubMedGoogle Scholar
• 181 Dormann A, Meisner S, Verin N et al. Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy 2004; 36: 543-550
  Article in Thieme ConnectPubMedGoogle Scholar
• 182 Telford JJ, Carr-Locke DL, Baron TH et al. Palliation of patients with malignant gastric outlet obstruction with the enteral Wallstent: outcomes from a multicenter study. Gastrointest Endosc 2004; 60: 916-920
  CrossrefPubMedGoogle Scholar
• 183 Khot UP, Lang AW, Murali K et al. Systematic review of the efficacy and safety of colorectal stents. Br J Surg 2002; 89: 1096-1102
  CrossrefPubMedGoogle Scholar
• 184 Dionigi G, Villa F, Rovera F et al. Colonic stenting for malignant disease: review of literature. Surg Oncol 2007; 16: S153-S155
  CrossrefPubMedGoogle Scholar
• 185 Sebastian S, Johnston S, Geoghegan T et al. Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction. Am J Gastroenterol 2004; 99: 2051-2057
  CrossrefPubMedGoogle Scholar
• 186 Athreya S, Moss J, Urquhart G et al. Colorectal stenting for colonic obstruction: the indications, complications, effectiveness and outcome--5 year review. Eur J Radiol 2006; 60: 91-94
  CrossrefPubMedGoogle Scholar
• 187 Repici A, Fregonese D, Costamagna G et al. Ultraflex precision colonic stent placement for palliation of malignant colonic obstruction: a prospective multicenter study. Gastrointest Endosc 2007; 66: 920-927
  CrossrefPubMedGoogle Scholar
• 188 Meisner S, Gonzalez-Huix F, Vandervoort JG et al. Self-expandable metal stents for relieving malignant colorectal obstruction: short-term safety and efficacy within 30 days of stent procedure in 447 patients. Gastrointest Endosc 2011; 74: 876-884
  CrossrefPubMedGoogle Scholar
• 189 van Hooft JE, Bemelman WA, Oldenburg B et al. Colonic stenting versus emergency surgery for acute left-sided malignant colonic obstruction: a multicentre randomised trial. Lancet Oncol 2011; 12: 344-352
  CrossrefPubMedGoogle Scholar
• 190 Lau G, Lai SH. Fatal retroperitoneal haemorrhage: an unusual complication of percutaneous endoscopic gastrostomy. Forensic Sci Int 2001; 116: 69-75
  CrossrefPubMedGoogle Scholar
• 191 Schurink CA, Tuynman H, Scholten P et al. Percutaneous endoscopic gastrostomy: complications and suggestions to avoid them. Eur J Gastroenterol Hepatol 2001; 13: 819-823
  CrossrefPubMedGoogle Scholar
• 192 Ubogu EE, Zaidat OO. Rectus sheath hematoma complicating percutaneous endoscopic gastrostomy. Surg Laparosc Endosc Percutan Tech 2002; 12: 430-432
  CrossrefPubMedGoogle Scholar
• 193 Ruthmann O, Seitz A, Richter S et al. [Percutaneous endoscopic gastrostomy. Complications with and without anticoagulation]. Chirurg 2010; 81: 247-254
  CrossrefPubMedGoogle Scholar
• 194 Richter JA, Patrie JT, Richter RP et al. Bleeding after percutaneous endoscopic gastrostomy is linked to serotonin reuptake inhibitors, not aspirin or clopidogrel. Gastrointest Endosc 2011; 74: 22-34e1
  CrossrefPubMedGoogle Scholar
• 195 Gerson LB, Tokar J, Chiorean M et al. Complications associated with double balloon enteroscopy at nine US centers. Clin Gastroenterol Hepatol 2009; 7: 1177-1182 e1–e-3
  CrossrefPubMedGoogle Scholar
• 196 Buscaglia JM, Dunbar KB, Okolo PI et al. The spiral enteroscopy training initiative: results of a prospective study evaluating the Discovery SB overtube device during small bowel enteroscopy (with video). Endoscopy 2009; 41: 194-199
  Article in Thieme ConnectPubMedGoogle Scholar
• 197 Moschler O, May A, Muller MK et al. Complications in and performance of double-balloon enteroscopy (DBE): results from a large prospective DBE database in Germany. Endoscopy 2011; 43: 484-489
  Article in Thieme ConnectPubMedGoogle Scholar
• 198 Vanbiervliet G, Giudicelli-Bornard S, Piche T et al. Predictive factors of bleeding related to post-banding ulcer following endoscopic variceal ligation in cirrhotic patients: a case-control study. Aliment Pharmacol Ther 2010; 32: 225-232
  CrossrefPubMedGoogle Scholar
• 199 Avgerinos A, Armonis A, Manolakopoulos S et al. Endoscopic sclerotherapy versus variceal ligation in the long-term management of patients with cirrhosis after variceal bleeding. A prospective randomized study. J Hepatol 1997; 26: 1034-1041
  CrossrefPubMedGoogle Scholar
• 200 de la Pena J, Rivero M, Sanchez E et al. Variceal ligation compared with endoscopic sclerotherapy for variceal hemorrhage: prospective randomized trial. Gastrointest Endosc 1999; 49: 417-423
  CrossrefPubMedGoogle Scholar
• 201 Hou MC, Lin HC, Kuo BI et al. The rebleeding course and long-term outcome of esophageal variceal hemorrhage after ligation: comparison with sclerotherapy. Scand J Gastroenterol 1999; 34: 1071-1076
  CrossrefPubMedGoogle Scholar
• 202 Petrasch F, Grothaus J, Mossner J et al. Differences in bleeding behavior after endoscopic band ligation: a retrospective analysis. BMC Gastroenterol 2010; 10: 5
  CrossrefPubMedGoogle Scholar
• 203 Baigent C, Blackwell L, Collins R et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373: 1849-1860
  CrossrefPubMedGoogle Scholar
• 204 Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857-867
  CrossrefPubMedGoogle Scholar
• 205 Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994; 89: 635-641
  CrossrefPubMedGoogle Scholar